Cationic Chitosan Derivatives for the Inactivation of HIV-1 and SARS-CoV-2 Enveloped Viruses.

Cele ZED, Matshe W, Mdlalose L, Setshedi K, Malatji K, Mkhwanazi NP, Ntombela T, Balogun M

Open source

DOI
10.1021/acsomega.3c02143
Published
2023 Sep 5
Container
ACS omega
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsomega.3c02143,
  title = {Cationic Chitosan Derivatives for the Inactivation of HIV-1 and SARS-CoV-2 Enveloped Viruses.},
  author = {Cele ZED and Matshe W and Mdlalose L and Setshedi K and Malatji K and Mkhwanazi NP and Ntombela T and Balogun M},
  year = {2023},
  journal = {ACS omega},
  doi = {10.1021/acsomega.3c02143},
  url = {https://doi.org/10.1021/acsomega.3c02143}
}

RIS

TY  - JOUR
TI  - Cationic Chitosan Derivatives for the Inactivation of HIV-1 and SARS-CoV-2 Enveloped Viruses.
AU  - Cele ZED
AU  - Matshe W
AU  - Mdlalose L
AU  - Setshedi K
AU  - Malatji K
AU  - Mkhwanazi NP
AU  - Ntombela T
AU  - Balogun M
PY  - 2023
JO  - ACS omega
DO  - 10.1021/acsomega.3c02143
UR  - https://doi.org/10.1021/acsomega.3c02143
ER  - 

APA

ZED, C., W, M., L, M., K, S., K, M., NP, M., T, N., & M, B. (2023). Cationic Chitosan Derivatives for the Inactivation of HIV-1 and SARS-CoV-2 Enveloped Viruses.. ACS omega. https://doi.org/10.1021/acsomega.3c02143

Source records